Societal CDMO, Inc. 3 SEC Filings

Filed On	Filing
25 Aug 2023	Form 3: Arens Mathew Paul, Director and 1 other Holds 635,000 shares of Common Stock
08 May 2023	Form 3: Awm Investment Company, Inc., 10% owner Holds 10,126,144 shares of Common Stock
24 Jan 2023	Form 3: Awm Investment Company, Inc., 10% owner Holds 8,846,052 shares of Common Stock
06 Sep 2022	Form 3: Cant Elena, Director No securities owned
19 Nov 2021	Form 3: Awm Investment Company, Inc., 10% owner Holds 5,281,901 shares of Common Stock
21 Jun 2021	Form 3: Parks Laura L., Director No securities owned
21 May 2021	Form 3: Awm Investment Company, Inc., 10% owner Holds 4,885,748 shares of Common Stock
12 Feb 2021	Form 3: Miller James Charles, Director No securities owned
18 Dec 2020	Form 3: Enloe J David Jr, Director No securities owned
12 Nov 2019	Form 3: Recro Pharma, Inc., 10% owner · Baudax Bio, Inc. Holds 100 shares of Common Stock
27 Mar 2019	Form 3: Ajdler Arnaud, Director Holds 1,064,546 shares of Common Stock
21 Aug 2017	Form 3: Mattila Jyrki, Executive VP, Business Dev. No securities owned
07 Jun 2017	Form 3: Lake Ryan David, Senior VP, Finance & CAO No securities owned
06 Mar 2017	Form 3: Reasons Bryan M., Director No securities owned
19 Dec 2016	Form 3: Stonepine Capital Management, Llc, 10% owner Holds 2,874,317 shares of Common Stock
16 Dec 2016	Form 3: Flynn James E, 10% owner and 5 others Holds 317,550 shares of Common stock
05 Jul 2016	Form 3: Celano Michael, Chief Financial Officer No securities owned
18 Feb 2016	Form 3: Graff Fred, Chief Commercial Officer No securities owned
02 Dec 2015	Form 3: McCallum Stewart, Chief Medical Officer No securities owned
08 Sep 2015	Form 3: Flynn Karen, Director No securities owned

Comments